AVM FRITZ! Mini / New: FRITZ! Mini Holds Music and Telephone in One Hand / Cordless Home Receiver for Calls, Audio and Online Info
mehr
Ergebnis der Suchanfrage nach @r@Mettmann@audio
Inhalte
- Kategorie:
- Sprache:
-
Medien:
Alle
- Zeitraum:
- Zeitraum:Gesamt
830 Treffer
AVM RadioFRITZ! and AVM VideoFRITZ!
mehrAVM's VDSL CPEs
mehrBoehringer Ingelheim Receives Recommendation From EU Scientific Committee for Sifrol(R)/ Mirapexin(R) (Pramipexole) for the Treatment of Restless Legs Syndrome (RLS)
Ingelheim, Germany (ots/PRNewswire) - - For Non-US Healthcare Professional Media Boehringer Ingelheim announced today that that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of Sifrol(R) / Mirapexin(R) ...
mehrBASF Makes All-Cash Proposal To Acquire Engelhard
Ludwigshafen, Germany (ots) - * BASF Intends To Offer US$37.00 Per Share For a Total of US$4.9 Billion * Acquisition Would Make BASF a Leading Provider in the Global Catalyst Business BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN), the world's leading chemical company, has made an all-cash proposal to acquire all outstanding shares of common stock of Engelhard ...
mehrNew Data Demonstrate Efficacy of Two Leading Anti-HIV Treatments
Dublin, Ireland, November 21 (ots/PRNewswire) - - New hope for HIV/AIDS patients: APTIVUS(R) outperforms several commonly prescribed drugs in the protease inhibitor (PI) class DUBLIN, Ireland, November 21 /PRNewswire/ -- - Experts Emphasize Need for Effective Therapy in Response to Increased Prevalence of HIV/AIDS throughout Europe At the 10th European AIDS Clinical Society (EACS) conference, experts ...
mehr
APTIVUS(R) Sustains Convincing Anti-HIV Effect Through 48 Weeks
Dublin, Ireland, November 21 (ots/PRNewswire) - - Additional Data Provide Further Guidance on Maximizing Treatment Response with APTIVUS(R) New data presented at the 10th European AIDS Conference (EACS) in Dublin demonstrate that through 48 weeks, APTIVUS(R) (tipranavir) provides a convincing and durable benefit, achieving and maintaining a superior treatment response in patients with resistant HIV.(1) ...
mehreuro adhoc: ElringKlinger AG / Financial Figures/Balance Sheet / Elring Klinger AG: Results for Q3 2005 and January 1 - Sept. 30, 2005
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 15.11.2005 ElringKlinger achieves 4 percent growth in sales revenues and 7 percent growth in net earnings in the first nine months Dettingen/Erms (Germany), November 15, 2005 --- The ...
mehreuro adhoc: OMV Aktiengesellschaft / Strategic management decisions / OMV sets new targets for further growth to 2010
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 12.10.2005 - Production target of 500,000 boe/d until 2010 - Further expansion of Refining and Marketing business in EU accession area - Expand gas marketing activities to 20 bcm of gas until ...
mehreuro adhoc: DocCheck AG / Board of Directors (Appointments and Changes) / Changes to the Board of Directors of DocCheck(R) AG
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 03.08.2005 Ad hoc Press Release Cologne, 3 August 2005 - At its meeting on 03.08.2005 the Supervisory Board of DocCheck(R) AG has decided to make some changes at Board level. A new appointment ...
mehreuro adhoc: DocCheck AG / Quarterly or Semiannual Financial Statements / In the second quarter DocCheck(R) AG has demonstrated an increase of 5 per cent
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 03.08.2005 Cologne, 3 August 2005 - DocCheck(R) AG, Cologne, (ISIN DE0005471007 // Symbol 547100), previously antwerpes ag, has achieved sales totalling 2.9 million euro in the 2nd quarter of ...
mehrPositive Opinion in Europe for Tipranavir
Rio De Janeiro, Brazil and Ingelheim, Germany (ots/PRNewswire) - - New Data Support its Use as Powerful Treatment Against HIV Drug Resistance RIO DE JANEIRO, Brazil and INGELHEIM, Germany, July 28 /PRNewswire/ -- Boehringer Ingelheim announced today that the CHMP (Committee for Medicinal Products for Human Use) in London has issued a positive opinion for tipranavir, a non-peptidic protease inhibitor, to ...
mehr
U.S. FDA Approves New Anti-HIV Drug Aptivus(R) for Use in Combination Therapy
Ridgefield, Connecticut (ots/PRNewswire) - - The Following Press Release Was Issued By Our U.S. Affiliate Boehringer Ingelheim Pharmaceuticals, Inc. in The United States on June 23, 2005 Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Aptivus(R) (tipranavir) ...
mehreuro adhoc: Software AG / other / Fujitsu and Software AG Announce a Strategic Alliance to Deliver a Joint Integration Offering for Service Oriented Architecture
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 01.03.2005 Fujitsu Limited and Software AG today announced their intent to jointly develop, market and sell an offering that will help customers improve business processes and increase ...
mehrEfficacy of Investigational Anti-HIV Agent Tipranavir Demonstrated by New Data
INGELHEIM, Germany,, February 28 (ots/PRNewswire) - - Tipranavir/r More Effective Than Lopinavir/r in Large-Scale Studies of Treatment-Experienced HIV-Positive Patients New data from multiple analyses presented last week at the 12th Conference on Retroviruses and Opportunistic Infections support the efficacy of the investigational non-peptidic protease ...
mehr1&1 Mail & Media Applications SE
euro adhoc: WEB.DE AG / Quarterly or Semiannual Financial Statements / Ad-hoc release in accordance with §15 WpHG: WEB.DE AG generated within its portal business segment 2004 revenues of EUR 42m, EBITDA of EUR 13m and operating cash flow of EUR 21m
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 27.01.2005 WEB.DE AG (ISIN DE 000 529 650 3), subdivided into its business segments Portal and Web-Telecommunications, has released preliminary figures for Q4/2004 and fiscal year 2004 which ...
mehreuro adhoc: Software AG / Board of Directors (Appointments and Changes) / Personnel: Software AG appoints Dr. Peter Kürpick to the Board of Directors
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Software AG has appointed Dr. Peter Kürpick to the Board of Directors with responsibility for the "XML Business Integration" division, to further expand this strategic business unit. The ...
mehrBoehringer Ingelheim Announces 24-Week Results From Second Phase III Pivotal Study of Tipranavir
Glasgow, Scotland, November 18 (ots/PRNewswire) - - RESIST-2 Data Demonstrate Efficacy in Treatment-Experienced Patient Population New tipranavir pivotal Phase III data show that a statistically significant higher percentage of treatment-experienced HIV-positive patients taking tipranavir therapy achieved treatment response versus those taking other ...
mehr
Boehringer Ingelheim Announces 24-Week Interim Results from Tipranavir RESIST-1 Phase 3 Study
Washington, November 1 (ots/PRNewswire) - New data from a pivotal Phase 3 study (RESIST-1) demonstrate that a statistically significant greater percentage of HIV-positive patients taking a tipranavir-based regimen achieved a treatment response versus those taking a regimen containing one of several marketed protease inhibitors (PIs). Treatment response in this study ...
mehrBoehringer Ingelheim Submits Marketing Authorisation Application to European Union and to the FDA for Investigational Anti-HIV Agent Tipranavir
Ingelheim, Germany (ots/PRNewswire) - Boehringer Ingelheim today announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for tipranavir. Simultaneously the documentation was submitted to the FDA. Tipranavir is a non-peptidic protease inhibitor (NPPI) for ...
mehr1&1 Mail & Media Applications SE
euro adhoc: WEB.DE AG / Quarterly or Semiannual Financial Statements / Ad hoc disclosure in accordance with §15 WpHG: WEB.DE grows strongly during the summer quarter and increases EBIT in the Portal business in Q1-Q3/2004 to 4.6 million Euro (EBIT margin
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. WEB.DE AG reports a very positive business development for the first nine months of fiscal 2004 (Q1-Q3/2004). During the reporting period WEB.DE AG raised revenues within the Group by 7.4 ...
mehreuro adhoc: Software AG / Board of Directors (Appointments and Changes) / Software AG aligns R&D with Business Lines - CTO resigns (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Software AG CEO, Karl-Heinz Streibich, is focusing the company on two strategic business lines. Product development for Enterprise Transaction Systems (Adabas and Natural) and XML Integration ...
mehreuro adhoc: OMV Aktiengesellschaft / Mergers - Acquisitions - Takeovers / OMV acquires a majority stake in SNP Petrom SA (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. - Acquisition of 51% stake in Petrom through a combination of a direct purchase of 33.34% and a simultaneous capital increase in Petrom - Group oil and gas reserves more than tripled: 1 billion ...
mehr1&1 Mail & Media Applications SE
euro adhoc: WEB.DE AG / Quarterly or Semiannual Financial Statements / WEB.DE grows strongly and increases portal-EBIT to EUR 2.9m and EBIT-margin to 15% in H1/2004 (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. WEB.DE AG once again reports on a very positive business development in the first half of fiscal 2004 (H1/2004): In second quarter of fiscal 2004 (Q2/2004) revenues rose to more than EUR 10 ...
mehr
Freudenberg & Co. Kommanditgesellschaft
Freudenberg Group completes portfolio restructuring
Weinheim (ots) - At the beginning of 2004, the Freudenberg Group completed a far-reaching reorientation of its portfolio, according to the report presented by Dr. Peter Bettermann, Speaker of the Management Board of Freudenberg & Co., at this year's annual press conference of the Group in Weinheim. Over the past five years, the Group has disposed of companies with annual sales totaling some 400 million Euro. The Group ...
mehr1&1 Mail & Media Applications SE
euro adhoc: WEB.DE AG / Quarterly or Semiannual Financial Statements / WEB.DE with 30% growth in revenues, a positive net result and positive EBITDA in Q1/2004 (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. WEB.DE AG reports a continuing positive business development in its review of the first quarter of fiscal 2004. In Q1/2004 year-on-year revenues increased by EUR +2.2 million or 30% to EUR 9.5 ...
mehrSAS at CeBIT 2004 in Hall 4, Stand D58: Focus Business Intelligence
Heidelberg (ots) - Business Intelligence in Practice: A Host of Software Applications at the SAS Stand - SAS demonstrates solutions for corporate governance/financial intelligence, customer relationship management and IT cost management The motto this year for SAS at CeBIT is "Focus Business Intelligence": The company will be presenting its current business intelligence portfolio in Hall 4, ...
mehrFreudenberg & Co. Kommanditgesellschaft
Freudenberg acquires Burgmann Dichtungswerke / Freudenberg and Burgmann to benefit jointly from global market opportunities
Wolfratshausen/Weinheim (ots) - Freudenberg & Co., Weinheim, has acquired large sections of Burgmann Dichtungswerke in Wolfratshausen, particularly those relating to the mechanical seals, expansion joints and automotive business, and is thus expanding its seals activities. "With the acquisition, we are ...
mehrSAS at CeBIT 2004: Leading business intelligence provider presents numerous new solutions in Hall 4, Booth D58
Heidelberg (ots) - SAS, the leading business intelligence provider, will present its latest business intelligence (BI) solutions at CeBIT in Hall 4, Booth D58. Particular focuses of attention will be the aspects of regulatory management (implementation, administration and monitoring of legal guidelines), customer ...
mehreuro adhoc: Software AG / Software AG to focus on two product lines (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. At todays meeting the Supervisory Board and Management Board of Software AG approved the strategic realignment. The key element is the focus on two product lines. 1. XML-based integration: Software AG will combine and enhance its products EntireX ...
mehr
Vorherige19202122232425262728Nächste